BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18173196)

  • 1. [Alterations in NK cell activity in the presence of sera of patients with metastases].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1994; 122 Suppl 1():78-80. PubMed ID: 18173196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
    Konjević G; Spuzić I
    J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomodulatory effect of serum on NK cells in vitro in healthy individuals].
    Konjević G; Spuzić I
    Glas Srp Akad Nauka Med; 1994; (44):45-54. PubMed ID: 7590414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possibilities of modulation of NK cell activity].
    Konjević G; Spuzić I
    Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of serum on NK cell activity].
    Konjević G; Spuzić I
    Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
    Konjević G; Spuzić I
    Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of determination of NK cell activity in malignant diseases].
    Spuzić I; Konjević G
    Glas Srp Akad Nauka Med; 1990; (39):153-60. PubMed ID: 2130019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in carcinoma of uterine cervix.
    Seth P; Balachandran N; Malaviya AN; Kumar R
    Clin Exp Immunol; 1979 Oct; 38(1):77-82. PubMed ID: 527257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steroid receptors and NK cell activity in patients with breast cancer].
    Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
    Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selenium, immunity and tumors].
    Spuzić I; Konjević G; Djarmati D
    Srp Arh Celok Lek; 1994; 122 Suppl 1():75-7. PubMed ID: 18173195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to guided imagery during breast cancer treatment.
    Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
    Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
    Basak PY; Adiloglu AK; Koc IG; Tas T; Akkaya VB
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):970-6. PubMed ID: 18482314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.
    Matsui M; Kishida T; Nakano H; Yoshimoto K; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Yoshimoto T; Hisa Y; Mazda O
    Cancer Res; 2009 Mar; 69(6):2523-30. PubMed ID: 19244121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15.
    Vojdani A; Mumper E; Granpeesheh D; Mielke L; Traver D; Bock K; Hirani K; Neubrander J; Woeller KN; O'Hara N; Usman A; Schneider C; Hebroni F; Berookhim J; McCandless J
    J Neuroimmunol; 2008 Dec; 205(1-2):148-54. PubMed ID: 18929414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
    Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.